IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,537 | +31.6% | 338 | +103.6% | 0.00% | – |
| Q2 2023 | $1,168 | +15.2% | 166 | 0.0% | 0.00% | – |
| Q1 2023 | $1,014 | +231.4% | 166 | +245.8% | 0.00% | – |
| Q4 2022 | $306 | – | 48 | -50.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 96 | -52.9% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 204 | -19.7% | 0.00% | – |
| Q1 2022 | $4,000 | -90.5% | 254 | -88.7% | 0.00% | – |
| Q4 2021 | $42,000 | -63.8% | 2,257 | -51.8% | 0.00% | – |
| Q3 2021 | $116,000 | +544.4% | 4,681 | +579.4% | 0.00% | – |
| Q2 2021 | $18,000 | +50.0% | 689 | +80.4% | 0.00% | – |
| Q1 2021 | $12,000 | -25.0% | 382 | +13.0% | 0.00% | – |
| Q4 2020 | $16,000 | +60.0% | 338 | +4.6% | 0.00% | – |
| Q3 2020 | $10,000 | +11.1% | 323 | -9.8% | 0.00% | – |
| Q2 2020 | $9,000 | +200.0% | 358 | +219.6% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 112 | +12.0% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -92.3% | 100 | -90.9% | 0.00% | – |
| Q3 2018 | $13,000 | +8.3% | 1,100 | +10.0% | 0.00% | – |
| Q2 2018 | $12,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $16,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | 0.0% | 1,000 | -3.6% | 0.00% | – |
| Q2 2017 | $8,000 | – | 1,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |